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We recently demonstrated that diacylglycerol induced arachidonate release and prostaglandin E, synthesis in 3T3 fibro- 
blasts, and greatly augmented prostaglandin E, synthesis in response to submaximal and maximal concentrations of 
bradykinin. We have now partially purified a phospholipase 4 from the cells. When phosphatidylPH]choline was used 
as substrate, several diacylglycerols augmented phospholipase 4 activity. Diacylglycerol was effective at concentrations 
as low as 30 nM. Protein kinase C inhibition did not affect diacylglycerol’s stimulation of phospholipase AZ. Diacyl- 
glycerol did not alter the calcium requirement for phospholipase A2 or its pH optimum. The present study demonstrates 
that the effect of diacylglycerol to augment arachidonate metabolism is at the level of phospholipase 4, itself. 
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1. INTRODUCTION 
We have shown that bradykinin stimulates 
phospholipase A2 (PLA2) activity in Swiss 3T3 
fibroblasts to release arachidonate for prostaglan- 
din E2 (PGE2) synthesis [I]. The primary substrate 
for the PLA2 appeared to be phosphatidylcholine. 
We have also shown that in these cells 
diacylglycerols stimulate basal arachidonate re- 
lease and PGE2 synthesis, and that diacylglycerols 
markedly augment PGE2 synthesis in response to 
bradykinin [2]. The site of diacylglycerol action 
was not defined, although protein kinase C (PKC) 
did not appear to be involved. 
In the present study, we have used a partially 
purified membrane-bound PLA2 from Swiss 3T3 
fibroblasts to demonstrate that the effect of 
diacylglycerol is at the level of PLA2. 
2.2. PLAz activity 
Correspondence address: R.M. Burch, Nova Pharmaceutical Phosphatidyl[3H]choline was prepared by incubation of 
Corporation, 6200 Freeport Centre, Baltimore, MD 21224, Swiss 3T3 fibroblasts with [‘HIcholine for 30-48 h. 
USA Phospholipids were extracted [3] and the lipids were subjected 
2. MATERIALS AND METHODS 
2.1. Purification of PLAz 
Swiss 3T3 fibroblasts were maintained as previously de- 
scribed [l]. Cells were harvested by scraping from the plates in 
phosphate-buffered saline and pelleted at 50000 x g for 10 min. 
The pellet was resuspended in 25 mM Tris-Cl (pH 7.4), 1 mM 
EGTA, 1 mM deoxycholate and 1 M KCl, and sonicated with 
a probe sonicator 4 times for 5 s each, with 30 s between each 
burst, in an ice bath. The Iysate was incubated at room 
temperature for 30 min, then centrifuged at 200000 x g for 
60 min. The supernatant was diluted in 100 vols of the same 
buffer without KCl, concentrated to 10 ml by ultrafiltration 
through an Amicon PM10 membrane, then applied to a DEAE- 
cellulose (Whatman DE-52) column (1 x 10 cm) that had been 
equilibrated with 25 mM Tris-Cl (pH 7.4) 1 mM EGTA, and 
1 mM deoxycholate. The column was eluted with 25 ml of the 
same buffer followed by a linear gradient of O-500 mM NaCl 
in the same buffer. Fractions of 2 ml were collected and PLAz 
activity was assayed at pH 7 and 9. A single peak of PLAa ac- 
tivity (pH 9) was eluted at 100-200 mM NaCl. No PLA2 was 
&ted that was more active at pH 7 than at pH 9. This partially 
purified enzyme was dialyzed against 20 mM Tris, pH 7, and 
used within 2 days. 
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to thin-layer chromatography [4]. The phosphatidylcholine 
fraction was scraped from the plate and was eluted with 
methanol, evaporated and stored in toluene/ethanol (50: 50). 
Phosphatidylcholine concentration was estimated by measuring 
lipid phosphorus content [5]. 
For assay, a reaction mixture was prepared by adding labeled 
phosphatidylcholine to a 20 ml glass vial, with diacylglycerol 
where appropriate. The substrate was evaporated under Nz, 
then resuspended in 100 mM Tris, pH 9 (or other pH in selected 
experiments), containing 1 mM CaClz and 1 mM deoxycholate 
to a final phosphatidylcholine concentration of 1OpM. The 
mixture was sonicated by probe 3 times for 5 s each, separated 
by 15 s intervals in an ice bath. For assay, 75 ~1 of this mixture 
was added to 12 x 75 mm glass tubes. The assay was begun by 
the addition of 25 ,~l of enzyme preparation and subsequent in- 
cubation at 37°C. The reaction was linear for at least 90 min. 
The reactions were terminated by the addition of 200~1 of 
methanol/chloroform/l N HCl (2: 1 :O.Ol), followed by 100~1 
of 2 M KCl. The phospholipids were separated by thin-layer 
chromatography [4], and lysophosphatidylcholine was scraped 
from the plate, eluted with methanol and radioactivity was 
quantitated by liquid scintillation spectroscopy. 
2.3. Materials 
All lipids were obtained from Sigma. Phorbol myristate 
acetate was obtained from Calbiochem. H-7 was obtained from 
Seikagaku America. 
3. RESULTS 
3.1. Stimulation of partially purified phospho- 
lipase A2 by diacylglycerols 
When oleoylacetylglycerol or dioleoylglycerol 
was present in the assay mixture, PLAz activity 
was markedly augmented (fig.1). A variety of 
diacylglycerols were able to stimulate PLAz activi- 
ty (table 1). Among those tested, stearoylarachi- 
donylglycerol has been shown to be a predominant 
diacylglycerol produced in cells [6]. Most of the 
diacylglycerols displayed similar effectiveness in 
stimulation of PLA2. However, oleoylacetylgly- 
cerol was consistently less effective than longer 
chain diacylglycerols (fig.1 and table 1). 
The concentration-response for stimulation of 
PLA2 by dioleoylglycerol is shown in fig.2. At a 
concentration as low as 0.03 FM, dioleoylglycerol 
significantly stimulated PLAz activity. Other 
diacylglycerols displayed similar concentration- 
response patterns (not shown). 
3.2. Role of protein kinase C in stimulation of 
PLA2 by diacylglycerols 
In our previous study [2], we demonstrated that 
diacylglycerols markedly augment arachidonate 
metabolism in Swiss 3T3 cells. While diacyl- 
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Fig. 1. Oleoylacetylglycerol (OAG) and dioleoylglycerol (diOG) 
stimulate PLAz activity. Data are triplicate tubes assayed at pH 
9 from 1 of 3 similar experiments. 
glycerols activated PKC in the cells, we excluded 
this enzyme from playing a major role in stimula- 
tion of arachidonate metabolism, since neither in- 
hibition nor down-regulation of PKC blocked 
diacylglycerols’ effects. In our partially purified 
PLAz preparation, under the conditions of the 
PLA2 assay, we detected no apparent PKC activity 
(table 2). However, if assay conditions were altered 
to be optimal for PKC, we did find evidence for 
protein kinase activity in the preparation (table 2). 
Thus, we tested the ability of the PKC inhibitor 
H-7 to affect diacylglycerol-stimulated PLA2 ac- 
tivity. Over a wide concentration range, H-7 did 
not affect diacylglycerol-stimulated PLA2 activity. 
In the presence of 100 PM H-7, 4835 it_ 370 cpm 
1ysoPC were formed, compared to 4886 f 322 cpm 
in the presence of dioleoylglycerol alone (1420 + 
235 cpm in the absence of dioleoylglycerol). As a 
Table 1 
Comparison of the ability of several diacylglycerols to stimulate 
PLA2 
LysoPC (cpm) 
Control 862 + 94 
Oleoylacetylglycerol, 5 pM 2654 k 285 
Dioleoylglycerol, 5 pM 3562 i 430 
Dipalmitoylglycerol, 5 pM 3238 + 264 
Stearoylarachidonylglycerol, 5 FM 3764 f 386 
Incubations were at pH 9 for 60 min at 37°C. Data are from 1 
of 2 similar experiments 
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Table 2 
Protein kinase C activity in the partially purified PLAz 
preparation 
cpm 32P into histone 
Control 
OAG, 5 PM 
PKC assay buffer + OAG 
Initial homogenate + OAG 
24 _t 20 
30 * 14 
96 & 24 
370 + 26 
Mean * SE of triplicate determinations in 1 of 2 similar 
experiments. Incorporation of “P from [y-32P]ATP into 
histone (type III-S) was assayed in the PLAz assay buffer plus 
radioactive ATP or in PKC assay buffer (4OOpg/ml 
phosphatidylserine, 1 mM CaC12, and 5 pM oleoylacetyl- 
glycerol (OAG) for 2 min) [14]. Homogenates of 3T3 cells were 
also assayed in PKC assay buffer and adjusted to the same 
amount of protein added (10 pg) as the partially purified PLAz 
preparation 
final test of whether PKC might mediate diacyl- 
glycerols’ ability to stimulate PLAz, we prepared 
membranes from Swiss 3T3 cells that had been 
pretreated with 1 PM phorbol myristate acetate for 
48 h, a treatment that completely down-regulates 
PKC [2]. Down-regulation of PKC had no effect 
on the ability of diacylglycerols to stimulate PLA2 
activity, since after down-regulation 3260 f 
386 cpm 1ysoPC was formed, compared to 3654 + 
diOG. UM 
Fig.2. Concentration-response for stimulation of PLA2 by 
dioleoylglycerol (diOG). Incubations were for 60 min at 37°C. 
Data are from 1 of 3 similar experiments. At 0.03 pM, 
dioleoylglycerol significantly stimulated PLA2 0, < 0.05) when 
all 3 experiments were compared by Student’s f-test for paired 
observations. 
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Fig.3. Effect of calcium on the ability of dioleoylglycerol 
(diOG) to stimulate PLAz. The ordinate is the amount of 
calcium added to. the assay buffer. Incubations were for 60 min 
at 37°C. Data are from 1 of 2 similar experiments. 
270 in the presence of dioleoylglycerol alone (con- 
trol 1128 f 145 cpm). 
3.3. Role of calcium in the ability of diacyiglycerol 
to stimulate PLAz 
Since most PLAzs require calcium for activity, 
we tested the effects of altered calcium concentra- 
tion on diacylglycerol-stimulated PLA2 activity. In 
the absence of added calcium, diacylglycerol did 
not stimulate PLA2 activity (fig.3). 
4. DISCUSSION 
The present study extends our previous observa- 
tion that diacylglycerol stimulates arachidonate 
metabolism in Swiss 3T3 cells. We have now 
shown that diacylglycerol acts at the level of PLA2 
itself, markedly stimulating activity of a PLAz par- 
tially purified from Swiss 3T3 cells. 
A variety of diacylglycerols were able to 
stimulate PLA2 activity. However, oleoylacetyl- 
glycerol was consistently less effective than longer- 
chain diacylglycerols. It has been previously shown 
that diacylglycerols cause restructuring of phos- 
pholipid vesicles [7]. This may allow PLAz more 
ready access to its substrate. 
It is particularly noteworthy that stearoylarachi- 
donoylglycerol, a diacylglycerol that is formed in 
response to activation of a number of receptors 
[6], stimulated PLA2 activity. We have no infor- 
mation about the mass of diacylglycerol formed in 
285 
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Swiss 3T3 cells in response to agonists. In platelets, 
however, diacylglycerol (4-l 1 nmol/lO’ platelets) 
is generated in response to receptor activation [S], 
amounting to perhaps 1-2 mol% of total phos- 
pholipid. In our experiments, 0.3 mol% diacylgly- 
cerol significantly stimulated PLA2. Thus, 
formation of diacylglycerol in response to receptor 
activation may be expected to stimulate PLA2. 
In our previous study utilizing intact Swiss 3T3 
cells, diacylglycerol stimulation of arachidonate 
metabolism appeared to be independent of PKC. 
Under the PLAz assay conditions of the present 
study, PKC activity could not be detected. Further 
evidence against participation of PKC were the 
findings that neither PKC inhibition nor down- 
regulation affected diacylglycerol stimulation of 
PLA2 activity. Also, experiments showed that in 
the absence of added calcium, PLA2 was not ac- 
tivated. In the absence of added calcium, free 
calcium in the buffer was likely several micromolar 
[9]. This concentration would be adequate to fully 
activate PKC in the presence of diacylglycerol. 
The mechanism by which diacylglycerol 
stimulated PLA2 activity is unclear. Diacylglycerol 
did not affect the calcium requirement of the en- 
zyme nor its pH optimum. The mechanism may 
relate to the ability of diacylglycerol to alter the 
structural organization of the substrate. It has 
been suggested that PLAz and PKC may contain 
similar regulatory sequences [lo]. Thus, similar to 
its effect on PKC [l 11, diacylglycerol may directly 
bind to PLA2 and activate it. Testing this possibili- 
ty awaits further purification of PLA2. 
Similar ability of diacylglycerol to stimulate 
phospholipases has been observed for purified 
phosphatidylinositol-specific phospholipase C 
[ 121, and other PLAzs [13]. However, this study 
correlated diacylglycerol activation of PLA2 to a 
biological effect, potentiation of PGE2 synthesis in 
response to receptor agonists [2]. This action of 
diacylglycerol may be physiologically relevant in 
that diacylglycerol, newly synthesized in response 
to a variety of agonists may activate PLA2, leading 
to arachidonate release and metabolism, or other 
biochemical events mediated by PLA2 metabolites. 
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